VitaNova Life Sciences Corporation Stock Price, News & Analysis
Company Description
VitaNova Life Sciences Corporation (OTC Link: VNOV) is a publicly traded medical distribution company in the Healthcare sector. The company has a market capitalization of $40.3M.
On a trailing twelve-month basis, VitaNova Life Sciences Corporation reported revenue of $2.7M with net income of $851K and diluted earnings per share of $0.03. The company operates at a net profit margin of 32.0%.
This page provides a comprehensive overview of VNOV stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Latest News
SEC Filings
VitaNova Life Sciences Corporation has filed 2 recent SEC filings, including 1 Form 8-K, 1 Form 10-Q. The most recent filing was submitted on March 18, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VNOV SEC filings →
Financial Highlights
VitaNova Life Sciences Corporation generated $2.7M in revenue over the trailing twelve months, retaining a 59.2% gross margin, operating income reached $1.2M (45.4% operating margin), and net income was $851K, reflecting a 32.0% net profit margin. Diluted earnings per share stood at $0.03. The company generated $193K in operating cash flow. With a current ratio of 5.90, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Days to Cover History
VNOV Company Profile & Sector Positioning
VitaNova Life Sciences Corporation (VNOV) operates in the Medical Distribution industry within the broader Healthcare sector and is listed on the OTC Link.